MeVis Medical Solutions AG/€M3V
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About MeVis Medical Solutions AG
MeVis Medical Solutions AG, headquartered in Bremen, Germany, develops and markets software solutions for the analysis and evaluation of medical imaging data. ([mevis.de](https://www.mevis.de/en/company/about-us/?utm_source=openai)) Founded in 1997, the company focuses on image-based early detection and diagnosis of diseases such as breast, lung, liver, and neurological disorders. ([eqs-news.com](https://www.eqs-news.com/company/mevis-medical-solutions-ag/info/5b865b3c-ea7c-11e8-902f-2c44fd856d8c?utm_source=openai)) Its software supports various imaging modalities, including X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. ([mevis.de](https://www.mevis.de/en/?utm_source=openai)) MeVis collaborates closely with medical device manufacturers and IT platform providers, offering services from product development to integration and quality assurance. ([eqs-news.com](https://www.eqs-news.com/company/mevis-medical-solutions-ag/info/5b865b3c-ea7c-11e8-902f-2c44fd856d8c?utm_source=openai)) In 2015, MeVis became part of Varian Medical Systems, and since 2017, it has been a subsidiary of Varex Imaging Corporation. ([de.wikipedia.org](https://de.wikipedia.org/wiki/MeVis_Medical_Solutions?utm_source=openai))
Ticker
€M3V
Sector
Primary listing
XETRA
Industry
Health Care Technology
Headquarters
Employees
114
ISIN
DE000A0LBFE4
Website
M3V Metrics
BasicAdvanced
€44M
10.28
€2.36
-0.20
€0.95
3.91%
Price and volume
Market cap
€44M
Beta
-0.2
52-week high
€25.80
52-week low
€24.60
Dividend rate
€0.95
Financial strength
Current ratio
4.208
Quick ratio
3.699
Profitability
EBITDA (TTM)
3.52
Gross margin (TTM)
35.62%
Net profit margin (TTM)
25.87%
Operating margin (TTM)
20.25%
Effective tax rate (TTM)
2.65%
Revenue per employee (TTM)
€150,000
Management effectiveness
Return on assets (TTM)
8.64%
Return on equity (TTM)
24.14%
Valuation
Price to earnings (TTM)
10.278
Price to revenue (TTM)
2.659
Price to book
2.49
Price to tangible book (TTM)
2.49
Dividend yield (TTM)
3.91%
Forward dividend yield
3.91%
Growth
Revenue change (TTM)
-5.72%
Earnings per share change (TTM)
-25.19%
3-year revenue growth (CAGR)
-0.09%
3-year earnings per share growth (CAGR)
-8.14%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MeVis Medical Solutions AG stock?
MeVis Medical Solutions AG (M3V) has a market cap of €44M as of July 05, 2025.
What is the P/E ratio for MeVis Medical Solutions AG stock?
The price to earnings (P/E) ratio for MeVis Medical Solutions AG (M3V) stock is 10.28 as of July 05, 2025.
Does MeVis Medical Solutions AG stock pay dividends?
Yes, the MeVis Medical Solutions AG (M3V) stock pays dividends to shareholders. As of July 05, 2025, the dividend rate is €0.95 and the yield is 3.91%. MeVis Medical Solutions AG has a payout ratio of 0% on a trailing twelve-month basis.
When is the next MeVis Medical Solutions AG dividend payment date?
The next MeVis Medical Solutions AG (M3V) dividend payment date is unconfirmed.
What is the beta indicator for MeVis Medical Solutions AG?
MeVis Medical Solutions AG (M3V) has a beta rating of -0.2. This means that it has an inverse relation to market volatility.